MeiraGTx Holdings plc

NASDAQ:MGTX

Biotechnology

Healthcare
$8.32 +5.08%

+$0.53 today

Market cap
$813.12M
Beta
1.26
P/E (TTM)
-7.4
EPS (TTM)
-$1.48
52W Low $6.07High $11.85

Volume 0.58M

Average 0.84M

MGTX Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

MeiraGTx Holdings plcNASDAQ: MGTX

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue falls 52.9% from a year ago

Deferred revenue stood at $2M at the end of Q1 FY2026, down 52.9% from a year earlier and up 12.4% from the prior quarter. Over 3 fiscal years it compounded at -51.0% a year.

Context

  • Deferred revenue amounted to 0.8% of total assets at the end of Q1 FY2026, down 1.1 pp from a year earlier.
  • Deferred revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps falling in the next quarterly balance sheet after a -52.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2M+12.4% QoQ
Last fiscal yearDec 2025
$1.78M-63.2% YoY
Year agoMar 2025
$4.24M-52.9% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-52.9%——
1 year-63.2%——
3-year CAGR-51.0%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
1.78M USD
Year-over-year change
-63.2%
4-year CAGR
-46.6%

Deferred Revenue vs competitors

How MGTX compares with its peers on the latest reported figures

  • MGTX's Mar 2026 deferred revenue of $2M is the 4th highest of the 9 companies compared; the peer median is $1.17M.
  • Its year-over-year change of -52.9% is the 2nd highest of 6, against a peer median of -58.4%.
  • Deferred revenue amounts to 0.8% of total assets for MGTX, versus a peer median of 0.8%.
MGTX Competitors Peer median
Deferred Revenue for MGTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
KRYSKrystal Biotech, Inc.Jun 2026$83.48M ——5.6%
RGNXREGENXBIO Inc.Mar 2026$5.92M -56.4%+78.8%1.7%
OCGNOcugen, Inc.Mar 2026$5.21M -32.4%-19.3%9.2%
MGTXMeiraGTx Holdings plcMar 2026$2M -52.9%-51.0%0.8%
LCTXLineage Cell Therapeutics, Inc.Mar 2026$1.72M -75.2%-29.3%1.6%
NTLAIntellia Therapeutics, Inc.Mar 2026$630K -97.0%-45.0%0.1%
FDMT4D Molecular Therapeutics, Inc.Mar 2026$360K -58.4%-25.9%0.1%
QUREuniQure N.V.Mar 2026$0 —+22.6%0.0%
SANASana Biotechnology, Inc.Mar 2026$0 ——0.0%
Peer median (excluding MGTX) $1.17M-58.4%-22.6%0.8%

Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents137.7M115.52M129.57M103.66M65.93M
Short-term Investments00000
Net Receivables35.02M29.02M23.42M10.63M18.29M
Inventory000385K0
Other Current Assets2.42M1.67M1.02M2.02M1.53M
Total Current Assets183.24M154.34M159.62M123.52M91.76M
Property, Plant & Equipment (Net)126.29M154.09M156.24M135.65M141.93M
Goodwill00000
Intangible Assets2.57M2.08M1.12M821K578K
Long-term Investments6.66M6.33M6.77M6.75M6.75M
Tax Assets00000
Other Non-current Assets1.4M1.4M3M3.01M3.41M
Total Non-current Assets136.92M163.9M167.12M146.23M152.67M
Total Assets320.16M318.24M326.74M269.75M244.43M
Account Payables15.35M16.62M16.04M23.59M10.07M
Short-term Debt000024.65M
Tax Payables00000
Deferred Revenue21.82M15.12M2.93M4.83M1.78M
Other Current Liabilities6.03M16.23M41.28M12.1M63.09M
Total Current Liabilities68.13M82.07M67.08M60.78M122.56M
Long-term Debt071.03M72.12M73.22M49.69M
Deferred Tax Liabilities196K186K000
Deferred Revenue (Non-current)43.05M27.44M34.02M57.58M65.12M
Other Non-current Liabilities3.03M2.44M2.4M2.82M1.4M
Total Non-current Liabilities66.64M118.43M121.49M141.14M127.67M
Total Liabilities134.76M200.5M188.57M201.92M250.22M
Common Stock2K2K2K3K3K
Retained Earnings(340.59M)(470.2M)(554.23M)(702.02M)(816.22M)
Accumulated OCI(2.67M)6.05M(1.44M)(3.72M)2.41M
Other Stockholders Equity00000
Minority Interest00000
Total Equity185.4M117.74M138.18M67.83M(5.79M)
Total Debt23.73M92.25M89.26M84.8M88.69M
Net Debt(113.97M)(23.27M)(40.3M)(18.86M)22.76M

MeiraGTx Holdings plc

NASDAQ:MGTX

Intrinsic Alpha fair value

Locked

Current Price

$8.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.